ABSTRACT
The nuclear medicine imaging is based on the assessment of radiotracer distribution in the organs after in vivo administration of a molecule containing radioactive atoms (radiopharmaceuticals) to distinguish between physiological and pathophysiological functions of the examined tissues.
